Hesperidin inhibits insulin-induced phosphoinositide 3–kinase/Akt activation in human pre-B cell line NALM-6 | Zendy

Roghayeh Shahbazi | Zendy; Makan Cheraghpour | Zendy; Reza Homayounfar | Zendy; Maryam Nazari | Zendy; Javad Nasrollahzadeh | Zendy; Sayed Hossein Davoodi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hesperidin inhibits insulin-induced phosphoinositide 3–kinase/Akt activation in human pre-B cell line NALM-6

Author(s) -

Roghayeh Shahbazi,

Makan Cheraghpour,

Reza Homayounfar,

Maryam Nazari,

Javad Nasrollahzadeh,

Sayed Hossein Davoodi

Publication year - 2018

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.157323

Subject(s) - protein kinase b , hesperidin , pi3k/akt/mtor pathway , chemistry , wortmannin , iκb kinase , phosphorylation , kinase , apoptosis , cytotoxic t cell , microbiology and biotechnology , biology , nf κb , biochemistry , medicine , in vitro , alternative medicine , pathology

It has been shown that hesperidin induces apoptosis in NALM-6 cells through inhibition of nuclear factor-kappa B (NF-κB) activation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research